genome editing | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

10,890 results for “genome editing”

Trials

View all 6814 →

Ascending Dose Study of Genome Editing by Zinc Finger Nuclease Therapeutic SB-FIX in Subjects With Severe Hemophilia B

1 participants · First posted Mar 1, 2016

Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-318 in Subjects With MPS I

3 participants · First posted Mar 8, 2016

Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-913 in Subjects With MPS II

9 participants · First posted Feb 2, 2017

Drugs

View all 1465 →

SaCas9-mediated in vivo genome editing therapy(Harvard University)

BCL11A CRISPR-Cas9 genome editing(Dana-Farber Cancer Institute)

SERPINA1 gene editing therapy (Korro Bio/Genevant Sciences)

Organizations

View all 60 →

Precision BioSciences

United States

Editas Medicine

United States

Sangamo Therapeutics

United States

News

View all 2551 →

APEC Economies Advance Genome Editing and Biotechnology to Strengthen Food Security

Quidditas Secures €2.62M to Advance Revolutionary Genome Editing Technology for Rare Disease Treatment

BRAIN Biotech Secures European Patent for Novel CRISPR-BMC Genome Editing Technology

Page 1 of 1089